Which has stronger valuation & earnings, HYPR or STRR?

Star Equity has higher revenue and earnings than Hyperfine. Star Equity is trading at a lower price-to-earnings ratio than Hyperfine, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hyperfine $11.40M 11.76 -$35.57M -$0.41 N/A Star Equity $172.16M 0.23 -$5.92M -$2.63 N/A

Is HYPR or STRR more profitable?

Star Equity has a net margin of -4.18% compared to Hyperfine's net margin of -226.88%. Star Equity's return on equity of -4.04% beat Hyperfine's return on equity. Company Net Margins Return on Equity Return on Assets Hyperfine -226.88% -98.83% -67.09% Star Equity -4.18% -4.04% -2.40%

Does the media prefer HYPR or STRR?

In the previous week, Hyperfine and Hyperfine both had 2 articles in the media. Star Equity's average media sentiment score of 1.26 beat Hyperfine's score of 0.93 indicating that Star Equity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hyperfine 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Star Equity 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer STEX or STRR?

In the previous week, Biosig Technologies and Biosig Technologies both had 2 articles in the media. Star Equity's average media sentiment score of 1.26 beat Biosig Technologies' score of 0.93 indicating that Star Equity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biosig Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Star Equity 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, STRR or CVRX?

Star Equity has higher revenue and earnings than CVRx. Star Equity is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Star Equity $172.16M 0.23 -$5.92M -$2.63 N/A CVRx $56.65M 2.41 -$53.31M -$2.02 N/A

Is STRR or CVRX more profitable?

Star Equity has a net margin of -4.18% compared to CVRx's net margin of -89.14%. Star Equity's return on equity of -4.04% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets Star Equity -4.18% -4.04% -2.40% CVRx -89.14% -120.76% -48.38%

Does the media favor STRR or CVRX?

In the previous week, Star Equity and Star Equity both had 2 articles in the media. Star Equity's average media sentiment score of 1.26 beat CVRx's score of 0.96 indicating that Star Equity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Star Equity 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CVRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, GUTS or STRR?

Star Equity has higher revenue and earnings than Fractyl Health. Star Equity is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Fractyl Health $90K 1,400.35 -$140.95M -$1.29 N/A Star Equity $172.16M 0.23 -$5.92M -$2.63 N/A

Does the media refer more to RCEL or STRR?

In the previous week, Avita Medical and Avita Medical both had 2 articles in the media. Star Equity's average media sentiment score of 1.26 beat Avita Medical's score of 0.93 indicating that Star Equity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Star Equity 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Star Equity (STRR) Competitors

$10.66 -0.31 (-2.83%)

Closing price 06/30/2026 04:00 PM Eastern

Extended Trading

$10.66 0.00 (0.00%)

As of 06/30/2026 04:10 PM Eastern

Compare

STRR vs. HYPR, STEX, CVRX, GUTS, and RCEL

Should you buy Star Equity stock or one of its competitors? MarketBeat compares Star Equity with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Star Equity include Hyperfine (HYPR), Biosig Technologies (STEX), CVRx (CVRX), Fractyl Health (GUTS), and Avita Medical (RCEL). These companies are all part of the "medical equipment" industry.

How does Star Equity compare to Hyperfine?

Hyperfine (NASDAQ:HYPR) and Star Equity (NASDAQ:STRR) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment.

15.0% of Hyperfine shares are owned by institutional investors. Comparatively, 3.8% of Star Equity shares are owned by institutional investors. 26.3% of Hyperfine shares are owned by insiders. Comparatively, 31.6% of Star Equity shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Hyperfine has a beta of 1.38, suggesting that its stock price is 38% more volatile than the broader market. Comparatively, Star Equity has a beta of 0.49, suggesting that its stock price is 51% less volatile than the broader market.

Star Equity has a net margin of -4.18% compared to Hyperfine's net margin of -226.88%. Star Equity's return on equity of -4.04% beat Hyperfine's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hyperfine	-226.88%	-98.83%	-67.09%
Star Equity	-4.18%	-4.04%	-2.40%

Star Equity has higher revenue and earnings than Hyperfine. Star Equity is trading at a lower price-to-earnings ratio than Hyperfine, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hyperfine	$11.40M	11.76	-$35.57M	-$0.41	N/A
Star Equity	$172.16M	0.23	-$5.92M	-$2.63	N/A

In the previous week, Hyperfine and Hyperfine both had 2 articles in the media. Star Equity's average media sentiment score of 1.26 beat Hyperfine's score of 0.93 indicating that Star Equity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hyperfine	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Star Equity	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hyperfine currently has a consensus target price of $1.78, suggesting a potential upside of 32.10%. Star Equity has a consensus target price of $28.00, suggesting a potential upside of 162.66%. Given Star Equity's higher probable upside, analysts clearly believe Star Equity is more favorable than Hyperfine.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hyperfine	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Star Equity	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.20

Summary

Star Equity beats Hyperfine on 9 of the 16 factors compared between the two stocks.

How does Star Equity compare to Biosig Technologies?

Biosig Technologies (NASDAQ:STEX) and Star Equity (NASDAQ:STRR) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership and analyst recommendations.

Star Equity has higher revenue and earnings than Biosig Technologies. Star Equity is trading at a lower price-to-earnings ratio than Biosig Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biosig Technologies	$40K	3,864.61	-$462.77M	-$9.71	N/A
Star Equity	$172.16M	0.23	-$5.92M	-$2.63	N/A

Biosig Technologies has a beta of 1.85, suggesting that its stock price is 85% more volatile than the broader market. Comparatively, Star Equity has a beta of 0.49, suggesting that its stock price is 51% less volatile than the broader market.

Biosig Technologies currently has a consensus price target of $8.00, suggesting a potential upside of 840.84%. Star Equity has a consensus price target of $28.00, suggesting a potential upside of 162.66%. Given Biosig Technologies' higher probable upside, research analysts plainly believe Biosig Technologies is more favorable than Star Equity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biosig Technologies	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Star Equity	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.20

Biosig Technologies has a net margin of 0.00% compared to Star Equity's net margin of -4.18%. Star Equity's return on equity of -4.04% beat Biosig Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biosig Technologies	N/A	-717.92%	-336.75%
Star Equity	-4.18%	-4.04%	-2.40%

7.2% of Biosig Technologies shares are owned by institutional investors. Comparatively, 3.8% of Star Equity shares are owned by institutional investors. 52.7% of Biosig Technologies shares are owned by insiders. Comparatively, 31.6% of Star Equity shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Biosig Technologies and Biosig Technologies both had 2 articles in the media. Star Equity's average media sentiment score of 1.26 beat Biosig Technologies' score of 0.93 indicating that Star Equity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biosig Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Star Equity	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Star Equity beats Biosig Technologies on 8 of the 15 factors compared between the two stocks.

How does Star Equity compare to CVRx?

Star Equity (NASDAQ:STRR) and CVRx (NASDAQ:CVRX) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

Star Equity presently has a consensus target price of $28.00, suggesting a potential upside of 162.66%. CVRx has a consensus target price of $11.50, suggesting a potential upside of 123.74%. Given Star Equity's higher possible upside, equities analysts clearly believe Star Equity is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Star Equity	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.20
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00

Star Equity has a beta of 0.49, indicating that its stock price is 51% less volatile than the broader market. Comparatively, CVRx has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market.

3.8% of Star Equity shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 31.6% of Star Equity shares are held by company insiders. Comparatively, 18.9% of CVRx shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Star Equity has a net margin of -4.18% compared to CVRx's net margin of -89.14%. Star Equity's return on equity of -4.04% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Star Equity	-4.18%	-4.04%	-2.40%
CVRx	-89.14%	-120.76%	-48.38%

Star Equity has higher revenue and earnings than CVRx. Star Equity is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Star Equity	$172.16M	0.23	-$5.92M	-$2.63	N/A
CVRx	$56.65M	2.41	-$53.31M	-$2.02	N/A

In the previous week, Star Equity and Star Equity both had 2 articles in the media. Star Equity's average media sentiment score of 1.26 beat CVRx's score of 0.96 indicating that Star Equity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Star Equity	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Star Equity beats CVRx on 8 of the 15 factors compared between the two stocks.

How does Star Equity compare to Fractyl Health?

Fractyl Health (NASDAQ:GUTS) and Star Equity (NASDAQ:STRR) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

Fractyl Health has a net margin of 0.00% compared to Star Equity's net margin of -4.18%. Star Equity's return on equity of -4.04% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fractyl Health	N/A	-4,053.15%	-96.41%
Star Equity	-4.18%	-4.04%	-2.40%

In the previous week, Star Equity had 1 more articles in the media than Fractyl Health. MarketBeat recorded 2 mentions for Star Equity and 1 mentions for Fractyl Health. Fractyl Health's average media sentiment score of 1.87 beat Star Equity's score of 1.26 indicating that Fractyl Health is being referred to more favorably in the media.

Company	Overall Sentiment
Fractyl Health	Very Positive
Star Equity	Positive

Fractyl Health presently has a consensus price target of $5.40, suggesting a potential upside of 579.76%. Star Equity has a consensus price target of $28.00, suggesting a potential upside of 162.66%. Given Fractyl Health's stronger consensus rating and higher possible upside, analysts clearly believe Fractyl Health is more favorable than Star Equity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Star Equity	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.20

Star Equity has higher revenue and earnings than Fractyl Health. Star Equity is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fractyl Health	$90K	1,400.35	-$140.95M	-$1.29	N/A
Star Equity	$172.16M	0.23	-$5.92M	-$2.63	N/A

Fractyl Health has a beta of 2.34, meaning that its stock price is 134% more volatile than the broader market. Comparatively, Star Equity has a beta of 0.49, meaning that its stock price is 51% less volatile than the broader market.

3.8% of Star Equity shares are held by institutional investors. 8.5% of Fractyl Health shares are held by insiders. Comparatively, 31.6% of Star Equity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Fractyl Health beats Star Equity on 9 of the 17 factors compared between the two stocks.

How does Star Equity compare to Avita Medical?

Avita Medical (NASDAQ:RCEL) and Star Equity (NASDAQ:STRR) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk, profitability and valuation.

27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 3.8% of Star Equity shares are owned by institutional investors. 2.8% of Avita Medical shares are owned by company insiders. Comparatively, 31.6% of Star Equity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Star Equity has a net margin of -4.18% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat Star Equity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
Star Equity	-4.18%	-4.04%	-2.40%

In the previous week, Avita Medical and Avita Medical both had 2 articles in the media. Star Equity's average media sentiment score of 1.26 beat Avita Medical's score of 0.93 indicating that Star Equity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Star Equity	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Avita Medical has a beta of 1.87, indicating that its share price is 87% more volatile than the broader market. Comparatively, Star Equity has a beta of 0.49, indicating that its share price is 51% less volatile than the broader market.

Star Equity has higher revenue and earnings than Avita Medical. Star Equity is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	1.78	-$48.59M	-$1.57	N/A
Star Equity	$172.16M	0.23	-$5.92M	-$2.63	N/A

Avita Medical presently has a consensus price target of $7.25, indicating a potential upside of 75.54%. Star Equity has a consensus price target of $28.00, indicating a potential upside of 162.66%. Given Star Equity's higher possible upside, analysts plainly believe Star Equity is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Star Equity	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.20

Summary

Avita Medical and Star Equity tied by winning 8 of the 16 factors compared between the two stocks.

Get Star Equity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STRR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

STRR vs. The Competition

Export

Metric	Star Equity	DIVERSIFIED OPS Industry	Multi-Sector Sector	NASDAQ Exchange
Market Cap	$40.54M	$17.55B	$16.22B	$12.45B
Dividend Yield	N/A	4.51%	4.23%	6.16%
P/E Ratio	-4.05	32.31	26.95	24.87
Price / Sales	0.23	6.08	5.17	102.84
Price / Cash	17.31	53.64	51.01	58.59
Price / Book	0.56	4.92	4.35	6.54
Net Income	-$5.92M	$929.92M	$920.57M	$336.70M
7 Day Performance	-4.01%	-2.14%	72.68%	2.81%
1 Month Performance	-8.89%	-5.03%	3.53%	0.58%
1 Year Performance	438.38%	19.27%	28.31%	31.29%

Star Equity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
STRR Star Equity	4.6272 of 5 stars	$10.66 -2.8%	$28.00 +162.7%	+433.0%	$40.54M	$172.16M	N/A	1,200	Positive News Gap Up
HYPR Hyperfine	3.034 of 5 stars	$1.46 -0.7%	$1.78 +22.1%	+87.6%	$144.93M	$15.33M	N/A	190
STEX Biosig Technologies	2.049 of 5 stars	$0.78 -8.9%	$8.00 +922.2%	N/A	$142.28M	N/A	N/A	50	Gap Up
CVRX CVRx	3.3058 of 5 stars	$5.16 +0.2%	$11.50 +122.9%	-12.6%	$136.93M	$59.07M	N/A	160
GUTS Fractyl Health	4.3861 of 5 stars	$0.78 -6.3%	$5.40 +596.8%	-51.0%	$122.95M	$90K	N/A	102	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:STRR) was last updated on 7/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Star Equity (STRR) Competitors

STRR vs. HYPR, STEX, CVRX, GUTS, and RCEL

How does Star Equity compare to Hyperfine?

Summary

How does Star Equity compare to Biosig Technologies?

Summary

How does Star Equity compare to CVRx?

Summary

How does Star Equity compare to Fractyl Health?

Summary

How does Star Equity compare to Avita Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STRR vs. The Competition

Star Equity Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Star Equity (STRR) Competitors

STRR vs. HYPR, STEX, CVRX, GUTS, and RCEL

How does Star Equity compare to Hyperfine?

Do insiders and institutionals hold more shares of HYPR or STRR?

Which has more volatility and risk, HYPR or STRR?

Is HYPR or STRR more profitable?

Which has stronger valuation & earnings, HYPR or STRR?

Does the media prefer HYPR or STRR?

Do analysts prefer HYPR or STRR?

Summary

How does Star Equity compare to Biosig Technologies?

Which has better earnings and valuation, STEX or STRR?

Which has more risk & volatility, STEX or STRR?

Do analysts prefer STEX or STRR?

Is STEX or STRR more profitable?

Do institutionals & insiders hold more shares of STEX or STRR?

Does the media prefer STEX or STRR?

Summary

How does Star Equity compare to CVRx?

Do analysts recommend STRR or CVRX?

Which has more volatility and risk, STRR or CVRX?

Do institutionals and insiders hold more shares of STRR or CVRX?

Is STRR or CVRX more profitable?

Which has preferable valuation & earnings, STRR or CVRX?

Does the media favor STRR or CVRX?

Summary

How does Star Equity compare to Fractyl Health?

Is GUTS or STRR more profitable?

Does the media prefer GUTS or STRR?

Do analysts recommend GUTS or STRR?

Which has higher earnings and valuation, GUTS or STRR?

Which has more volatility & risk, GUTS or STRR?

Do institutionals & insiders hold more shares of GUTS or STRR?

Summary

How does Star Equity compare to Avita Medical?

Do institutionals and insiders believe in RCEL or STRR?

Is RCEL or STRR more profitable?

Does the media refer more to RCEL or STRR?

Which has more volatility & risk, RCEL or STRR?

Which has preferable valuation and earnings, RCEL or STRR?

Do analysts rate RCEL or STRR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STRR vs. The Competition

Star Equity Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools